MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cholesterol lowering'. Sat, 03 Sep 2011 02:30:04 +0100 http://www.medworm.com/index.php?rid=4031241&cid=t_121761_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fthe-simple-truth-about-cholesterol%2F2010.10.05 The New York Times recently ran a piece that wondered if doctors were treating patients with cholesterol-lowering medication unnecessarily because a web-based calculator over estimated a person’s risk. The program was proudly sponsored by the pharmaceutical roundtable and was available at the American Heart Association. The implication was obvious. Simple tool determines an individual’s risk for heart attack or death from heart attack. It over estimates risk. Patients treated unnecessarily. To be also clear, the program did underestimate risk as well. Unfortunately, the article missed an important point. While the simplified calculator may not be as accurate as the more complex algorithm used by the National Cholesterol Education Program, the truth is doctors are likely to... Better Health blogs http://www.medworm.com/rss/comments.php?id=4031241 Tue, 05 Oct 2010 12:00:00 +0100 4031241 http://www.medworm.com/index.php?rid=2857461&cid=t_121761_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FliwUHmPfIZ0%2F A three-year study of 170,024 patients has found that two low-cost medications – one for lowering cholesterol and one for lowering blood pressure – taken for two years reduced their risk of having a heart attack or stroke by more than 60% for the following year. The patients were divided into three groups at the start of the study. The high-exposure group was composed of 21,292 patients. They took both medications  (40 milligrams of lovastatin and 20 milligrams of lisinopril) more than half the time throughout the two years. The amount of time they took the medications was determined by a review of pharmacy records. The low-exposure group of 47,268 people took the two medications less than half the time, while 101,464 people did not take the medications and were considered to ... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2857461 Sat, 03 Oct 2009 02:59:24 +0100 2857461 http://www.medworm.com/index.php?rid=1375200&cid=t_121761_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F271000486%2F Administration of the popular anti-inflammatory drug Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) in combination with Lipitor (atorvastatin, a cholesterol lowering drug or statin) halts the transition of early prostate cancer to its more aggressive and potentially deadly stage. “Anti-androgen therapy slows the prostate cancer but eventually the cancer becomes androgen-independent, the therapy becomes ineffective and the cancer cells become more aggressive,” said Xi Zheng, assistant research professor at Rutgers, The State University of New Jersey, who conducted the study. “Treatments available for the later stage cancers are not very good,” said Allan Conney, director of Rutgers’ Susan Lehman Cullman Laboratory for Cancer Research, another resea... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1375200 Tue, 15 Apr 2008 22:02:12 +0100 1375200 http://www.medworm.com/index.php?rid=1142789&cid=t_121761_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F214472762%2F According to Wildon Farwell, M.D., of the Veterans Affairs Boston Healthcare System and colleagues, patients that are on cholesterol-lowering drugs – statins – may be at a lower risk for developing cancer — especially lung and colorectal cancers. Statin users had a reduced risk of all cancer types compared with non-statin users. The incidence of cancer was 9.4 percent among statin users and 13.2 percent among non-statin users. “Our findings support the hypothesis that statins may reduce the risk of cancer, in particular lung and colorectal cancers. This relationship may be affected by the [statin dose],” the authors write. While it is not known if statins can directly prevent cancer, they may inhibit growth of cancer cells – at least according to lab studies. Find m... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1142789 Thu, 10 Jan 2008 16:01:08 +0100 1142789 http://www.medworm.com/index.php?rid=795105&cid=t_121761_87_f&fid=34866&url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F08%2F13%2Fsterols-and-stanols-heart-health-super-duo%2F Filed under: Diet, Prevention, NutritionTwo grams per day of sterols and/or stanols can promote heart health, reducing cholesterol levels by around ten percent in as little as two weeks. They are most beneficial for people whose cholesterol levels are already elevated. According to one study, sterols and stanols together are more effective than a double-dose of cholesterol-lowering medications! Not bad for a bunch of little-known plant compounds, huh?The catch with sterols and stanols is working out how to get enough. Two grams daily. Doesn't sound like much. And, true, sterols and stanols are found in a great many foods - avocados, corn oil, apples, oranges, beans and peanut butter, to name a few. But they occur in minute amounts, making it hard to get as much as two grams daily. Example?... The Cardio Blog blogs http://www.medworm.com/rss/comments.php?id=795105 Mon, 13 Aug 2007 04:00:00 +0100 795105 http://www.medworm.com/index.php?rid=587882&cid=t_121761_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F03%2Ftoo-much-insulin-could-lead-to-heart-disease%2F Filed under: Type 2, Adult Onset, Lifestyle, Drugs, Research, Daily NewsResearchers defined a link between high insulin levels and defective lipid metabolism but the cause may not be exactly what you think. According to a study published in June, 2005 -- this could be due to their choice in blood sugar lowering medication. The conclusion of the study identified obese insulin-resistant subjects taking metformin (brand names Glucophage, Diabex, Diaformin, Fortamet, Riomet, Glumetza) and rosiglitazone both improve insulin sensitivity (increase insulin production) but DO NOT improve lipid metabolism. Rosiglitazone (brand name Avandia) may have a detrimental effect on chylomicron metabolism Blood vessels of insulin-resistant rats build up a substance called chylomicron cholesterol following a ... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=587882 Thu, 03 May 2007 04:00:00 +0100 587882